Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
about
Percutaneous patent foramen ovale closure for cryptogenic stroke: learning from clinical trial and error.Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.Patent foramen ovale and cryptogenic stroke: contemporary evidence and treatment.Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017.Acute Hypoxic and Refractory Respiratory Failure Induced by an Underlying PFO: An Unusual Case of Platypnea Orthodeoxia and Transient Complication after Transcatheter Closure.Response by Merkler et al to Letter Regarding Article, "Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale".Transcatheter closure of patent foramen ovale for secondary prevention of ischemic stroke: Quantitative synthesis of pooled randomized trial data.Highlights From the 2017 Cardiovascular and Stroke Nursing Clinical Symposium.Paradoxical emboli following a pulmonary embolus in the presence of a patent foramen ovale.Closure of patent foramen ovale in "cryptogenic" stroke: Has the story come to an end?Percutaneous closure of a patent foramen ovale after cryptogenic stroke.[Therapy changes after stroke in patients with open foramen ovale? : Patent Foramen Ovale Closure or Anticoagulants versus Antiplatelet Therapy to Prevent Stroke Recurrence Trial (CLOSE), Randomized Evaluation of Recurrent Stroke Comparing PFO ClosuCorrespondence (reply): In Reply:.Association of Preoperatively Diagnosed Patent Foramen Ovale With Perioperative Ischemic Stroke.PFO Closure and Stroke.Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials.PFO closure in high-risk patient with paradoxical arterial embolism, deep vein thrombosis, pulmonary embolism and factor V Leiden genetic mutation.Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: Meta-Analysis of Five Randomized Controlled Trials with 3440 Patients.Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.Updates on Prevention of Cardioembolic Strokes.Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis.Patent foramen ovale closure reduces recurrent stroke risk in cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guidelinePatent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidencePatent foramen ovale closure versus medical therapy for stroke prevention: A systematic review and meta-analysis of randomized controlled trialsManagement of patent foramen ovale in patients with cryptogenic stroke: Is device closure superior to medical treatment? A brief reviewPatent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke preventionPatent foramen ovale in an old patient with ischemic stroke following carotid surgeryPatent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?Patent foramen ovale closure or medical therapy for secondary prevention of cryptogenic stroke: An update meta-analysis of randomized controlled trialsCardioembolic stroke: everything has changed
P2860
Q47148234-4B3978AB-7AEB-42D3-882F-C6C6E30558B3Q47260521-5A336E39-388D-4E55-B469-133B0DA327D9Q47562490-3824F4AF-024A-4332-A96E-570E7A710BE2Q47660182-D6CCAADC-3CA2-4795-877C-F4AC26B9D0E4Q47661577-162B95D5-D169-4E43-AB42-333A5AEBECFAQ47945959-CA6DA97D-A7D1-46B1-8FD9-83808484CC9CQ48247951-E44DF223-5682-47B4-BF88-B7A8AC653C0DQ49233860-EEF17101-3ED9-43FB-81D7-C4C2966D08CBQ49293334-084CB627-4200-49C4-9ACA-D415CAAF95C5Q49330256-4D9A58EE-6F50-460F-AB94-7F5E3418B32AQ49591116-961A0DF4-D227-41BE-94DB-65C28FFD0A44Q50098455-9B732671-BCE6-493B-998C-9106F386252EQ50143498-EC658236-BC38-43C7-8077-316018BD419EQ50146736-2BE61D30-ABFE-4302-93A9-C5743075F7F6Q50333463-628083A4-416D-446B-AE45-15730EB53B0AQ51733405-DEECF3C2-78E9-4B3A-9C40-36758812539EQ52632545-D3862519-F9BD-4E61-A510-DD3DB1F489E1Q53832627-94868512-19CD-43A8-8B24-CD5042C74893Q55352254-15857EA9-10FE-449E-9072-3E9B620DA66BQ55359342-D131A595-0FD2-4B10-A2AA-56F96E19A8BBQ55363978-1347CFD9-380F-40C1-911A-302BE7287CBAQ55505555-8ABD8B62-0F11-4B20-A3CB-503F3AB1F90FQ56566721-3F674139-CD6B-4306-BEA4-A42AA80A58F3Q56804853-27290BB3-2364-46E9-9606-1EC8C5D2AB46Q57150942-CBC7BBDA-4C0E-4756-8156-929FC2836FBEQ57652818-10B00669-48AF-4852-AC04-12B59D643749Q57652832-EC989828-78CF-464D-A26E-5AC708B21199Q57824558-82FA01AA-E8B3-4CB5-B7BC-A6A025385DB9Q58564236-11E981E6-C3B9-4A24-BDAF-405F557BF3B5Q58706609-50CCAE55-72AA-42A9-A96A-F276BC65C1B7Q58769055-10E73F75-298B-4BB7-8687-156C40295850
P2860
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
@en
type
label
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
@en
prefLabel
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
@en
P2093
P50
P356
P1476
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
@en
P2093
Anaïs Charles-Nelson
Anna Ferrier
Benoît Guillon
Bernard Bertrand
CLOSE Investigators
Caroline Arquizan
Catherine Lefebvre
Claudia Vaduva
Céline Guidoux
Denis Sablot
P304
P356
10.1056/NEJMOA1705915
P407
P50
P577
2017-09-01T00:00:00Z